Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(5 sites)
United States
UCLA Vatche & Tamar Manoukian Division of Digestive Diseases, Los Angeles, California Mayo Clinic, Rochester, Minnesota NYU Langone Health, New York, New York University of North Carolina, Chapel Hill, North Carolina Allegheny Health Network, Pittsburgh, Pennsylvania Last updated January 2026